July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Check out the state of immunotherapy in resectable NSCLC – FDA Oncology
May 27, 2024, 07:35

Check out the state of immunotherapy in resectable NSCLC – FDA Oncology

FDA Oncology shared a post on X:

“Check out the state of immunotherapy in resectable NSCLC: This ASCO Ed Book article includes views from academia & FDA. Good warmup for ASCO 24 Education Session ‘Integrating Immunotherapy into Early-Stage Lung Cancer’ on June 2.

→ Ongoing trials of immunotherapy and RT for early stage NSCLC.
→ Clinical implications of recent advances in immunotherapy for resectable NSCLC.
→ Current trial designs assessing immunotherapy in resectable NSCLC: challenges, opportunities.”

View additional information.
Source: FDA Oncology/X
.